In 2006, one meta-analysis of 130 studies (over 23,000 cases and 30,000 controls) reported the weakly positive, but not significant association between the GSTM1 null genotype and the risk of lung cancer [21]. This evidence concerns the gene GSTM1 and lung carcinoma.